SCHEMBL22700976

SCHEMBL22700976

C=CCOc1ccc(CC=C)c(-c2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FGFR1 P11362 1/20 0.43
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA9 Q16790 5/20 0.41
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
BCHE P06276 1/20 0.38
ALDH2 P05091 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
BACE1 P56817 1/20 0.38
FFAR1 O14842 1/20 0.37
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11127266 0.80 MEN1 (0.48) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL28541485 0.77 GABRA1 (0.47) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL8850740 0.77 GAA (0.49) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL472119 0.75 BACE1 (0.51) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL27886719 0.75 GABRA1 (0.47) MEN1MAPTKMT2AGAA
SCHEMBL5095993 0.74 GAA (0.47) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL22700982 0.74 ALDH1A1 (0.48) MEN1LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL22701020 0.74 GABRA1 (0.41) MAPTCA12CA1CA9KDM4E
SCHEMBL4981424 0.74 LTA4H (0.47) FGFR1BCHEBACE1KDM4ENPC1
SCHEMBL19692650 0.73 KDM1A (0.47) MEN1LMNAMAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807596-B2 Thiol compounds, synthesis method therefor, and utilization of said thiol compounds SHIKOKU CHEMICALS CORPORATION (JP) 2023-11-07 US disclosed
US-11807596-B2 Thiol compounds, synthesis method therefor, and utilization of said thiol compounds SHIKOKU CHEMICALS CORPORATION (JP) 2023-11-07 US disclosed
US-20200369606-A1 THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS SHIKOKU CHEMICALS CORPORATION (JP) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369606-A1 THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS TMT1A, CTH, SLC7A11 MEN1 4522/4885LMNA 4672/4885MAPT 2185/4885
US-11807596-B2 Thiol compounds, synthesis method therefor, and utilization of said thiol compounds TMT1A, CTH, SLC7A11 MEN1 4522/4885LMNA 4672/4885MAPT 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.